Type(s) of Cancer
Breast
Breast
Study Phase
Phase 2B
Study Completion Date
August 2014
August 2014
NCT00861705Uploaded 04-14-2017
Available for Download
PDS UID: Breast_Allianc_2009_162
Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer
Files:
PROTOCOL40603 protocol.pdf
CRF40603_CRF.pdf
DATA DICTIONARY40603_datadictionary.pdf
DATA (ACTIVE ARM)treated2.csv
DATA (ACTIVE ARM)aeclean.csv
DATA (ACTIVE ARM)PoC_aeclean_xomic.csv
DATA (ACTIVE ARM)PoC_treated2_xomic.csv